Life Sciences/Biotech

MSU, VAI Researchers Closer To Cure For Parkinson’s Disease

GRAND RAPIDS - Researchers from Michigan State University, Van Andel Institute and Sweden are closer to developing new drugs that target Parkinson's disease. The researchers have shown significant associations between high levels of pro-inflammatory markers in cerebrospinal fluid and severity of fatigue, depression, anxiety and cognitive impairment in individuals with Parkinson?s disease. ?We hypothesized that

By |2013-08-27T00:00:00-04:00August 27th, 2013|Archive, Life Sciences/Biotech|

Henry Ford CC Gets $100K Grant To Make Nanotech Available For Students

DEARBORN - Henry Ford Community College's biotechnology program has received a $100,000 grant from the Community Foundation for Southeast Michigan to help the college make nanotechnology and microsystems training available for community college students. The grant seeds a partnership between HFCC?s biotechnology program, the University of Michigan Lurie Nanofabrication Facility, the National Nanotechnology Infrastructure Network

By |2013-08-22T00:00:00-04:00August 22nd, 2013|Archive, Life Sciences/Biotech|

Kalamazoo Valley CC Selects Downtown Location For Food Nutrition Center

KALAMAZOO - Kalamazoo Valley Community College announced the selection of a downtown location where it will expand its curriculum to include training in sustainable food production, distribution and preparation; all part of the college?s efforts to increase community understanding of and access to healthy food and nutrition. The program is in partnership with Bronson Healthcare

By |2013-07-31T00:00:00-04:00July 31st, 2013|Archive, Life Sciences/Biotech|

Van Andel Institute Researchers Map Molecular Structure Of Cancer Drug Target

GRAND RAPIDS - Van Andel Institute researchers have mapped the complex molecular structure of a folate receptor, a drug target for a number of cancers and other diseases, a first-of-its-kind discovery that may lead to the development of more precise, consistent and effective treatments. In an international collaboration published online this week in the journal

By |2013-07-17T00:00:00-04:00July 17th, 2013|Archive, Life Sciences/Biotech|

Wayne State Awards 2 Grants For $1.8 Million To Fund Multidisciplinary Research

DETROIT - Wayne State University announced Thursday two research grants totaling $1.8 million in the Multidisciplinary Research Group Incubator Program, an internal funding program at the university. The seed-funding program is aimed at fostering the development of multidisciplinary research groups with significant growth potential for external funding through centers of excellence grant programs, program project

By |2013-06-21T00:00:00-04:00June 21st, 2013|Archive, Life Sciences/Biotech|

MSU Breaks Ground On $60.8 Million Bioengineering Facility

EAST LANSING - Michigan State University on Wednesday broke ground on a new $60.8 million Bioengineering Facility, which will serve as a hub for interdisciplinary research in MSU's colleges of Engineering, Human Medicine and Natural Science. Some $30 million came from the state and the rest from the university. The facility will cover about 130,000

By |2013-06-20T00:00:00-04:00June 20th, 2013|Archive, Life Sciences/Biotech|

RTI Biologics To Acquire Pioneer Surgical Technology For $130 MIllion

FARMINGTON HILLS - Beringea announced that RTI Biologics, a provider of orthopedic and other biologic implants, plans to pay $130 million to acquire Marquette-based Pioneer Surgical Technology, a Beringea portfolio company. Pioneer Surgical manufactures and distributes metal and synthetic products in the orthopedics, biologics, spine, trauma and cardiothoracic markets. Under the terms of the merger

By |2013-06-19T00:00:00-04:00June 19th, 2013|Archive, Life Sciences/Biotech|

Perrigo Puchases Fera Pharma $93 Milion In Cash, Contingent Payments

ALLEGAN - Perrigo Co. said Monday it had purchased the ophthalmic sterile ointment and solution portfolio of Fera Pharmaceuticals LLC and its affiliates for an upfront payment of $93 million along with potential contingent payments of $36 million, some of which relate to Perrigo securing more product rights from Fera. Perrigo said the purchase expands

By |2013-06-18T00:00:00-04:00June 18th, 2013|Archive, Life Sciences/Biotech|